BrightView Health Arlington

Contact Information
339 Massachusetts Avenue , Arlington, Massachusetts 2474, United States
Detailed Information

BrightView Health Arlington

    Services:
    Pharmacotherapies

    • Disulfiram
    • Nicotine replacement
    • Buprenorphine (extended-release, injectable)
    • Naltrexone (oral)
    • Naltrexone (extended-release, injectable)
    • Buprenorphine without naloxone
    • Buprenorphine sub-dermal implant
    • Buprenorphine with naloxone
    • Non-nicotine smoking/tobacco cessation
    • Acamprosate (Campral®)

    Treatment Approaches

    • Matrix Model
    • Telemedicine/telehealth therapy
    • Brief intervention
    • Substance use disorder counseling
    • Trauma-related counseling
    • Motivational interviewing
    • Relapse prevention
    • Contingency management/motivational incentives
    • Cognitive behavioral therapy
    • Community reinforcement plus vouchers

    Facility Vaping Policy

    • Vaping permitted in designated area

    Recovery Support Services

    • Housing services
    • Mentoring/peer support
    • Assistance with obtaining social services

    External Source of Medications Used for Alcohol Use Disorder Treatment

    • In-network prescribing entity

    Type of Alcohol Use Disorder Treatment

    • This facility administers/prescribes medication for alcohol use disorder

    Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

    • Intensive outpatient treatment
    • Outpatient methadone/buprenorphine or naltrexone treatment
    • Outpatient detoxification
    • Regular outpatient treatment
    • Outpatient day treatment or partial hospitalization
    • Outpatient

    Language Services

    • Sign language services for the deaf and hard of hearing

    Assessment/Pre-treatment

    • Comprehensive substance use assessment
    • Screening for tobacco use
    • Screening for substance use

    Testing

    • Drug or alcohol urine screening

    Ancillary Services

    • Case management service
    • Social skills development

    Facility Operation (e.g., Private, Public)

    • Private for-profit organization

    Gender Accepted

    • Female
    • Male

    Detoxification (medical withdrawal) Services

    • Opioids detoxification
    • Alcohol Detoxification
    • Cocaine Detoxification
    • Benzodiazepines Detoxification
    • Medication routinely used during detoxification
    • Methamphetamines detoxification

    External Opioid Medications Source

    • In-network prescribing entity

    Type of Care

    • Substance use treatment
    • Detoxification

    Age Groups Accepted

    • Adults
    • Young Adults

    Payment/Insurance/Funding Accepted

    • Cash or self-payment
    • Private health insurance
    • State-financed health insurance plan other than Medicaid
    • Federal military insurance (e.g., TRICARE)
    • Medicaid
    • Medicare

    Education and Counseling Services

    • Individual counseling
    • Group counseling
    • Substance use disorder education

    Opioid Medications used in Treatment

    • Naltrexone used in Treatment
    • Buprenorphine used in Treatment

    Special Programs/Groups Offered

    • Adult men
    • Pregnant/postpartum women
    • Adult women

    Transitional Services

    • Discharge Planning
    • Naloxone and overdose education
    • Aftercare/continuing care
    • Outcome follow-up after discharge

    Type of Opioid Treatment

    • Maintenance service with medically supervised withdrawal after stabilization
    • Prescribes naltrexone
    • Buprenorphine detoxification
    • Relapse prevention with naltrexone
    • Buprenorphine maintenance
    • Accepts clients using MAT but prescribed elsewhere
    • Prescribes buprenorphine

    Facility Smoking Policy

    • Smoking permitted in designated area

    License/Certification/Accreditation

    • The Joint Commission
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm